在动脉样硬化中,LDL胆固醇和Lp (a) 对单细胞和巨细胞的影响
Sabina Ugovšek1,2, Jernej Jeras2,3, Miran Šebeštjen1,2,4
1Department of Cardiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Biochemia medica
|October 17, 2025
概括
单细胞和巨细胞通过与低密度脂蛋白 (LDL) 胆固醇和脂蛋白 (Lp) 相互作用驱动动动脉硬化. 这种相互作用促进炎症,泡细胞形成和急性心血管事件.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 脂质代谢 脂质代谢是什么
背景情况:
- 动脉样硬化涉及脂蛋白和炎症细胞之间的复杂相互作用.
- 单细胞和巨细胞是动脉生成中的关键免疫细胞,对LDL胆固醇和Lp (a) 等动脉生成性脂蛋白做出反应.
- 升高的LDL胆固醇和Lp (a) 促进一种亲炎性单细胞/巨细胞表型,导致泡细胞形成和细胞因子释放.
研究的目的:
- 要总结单细胞和巨细胞在动脉样硬化中的关键作用.
- 探索LDL胆固醇和Lp (a) 如何在动脉生成过程中影响单细胞和巨细胞的行为.
主要方法:
- 关于单细胞/巨细胞参与动脉样硬化的现有文献的综述.
- 对将LDL胆固醇和Lp (a) 与单细胞/巨细胞激活联系起来的分子机制的分析.
- 检查C-C化学受体2型 (CCR2) 在单细胞迁移中的作用.
主要成果:
- 单细胞和巨细胞有助于促炎循环,释放细胞因子,进一步氧化脂蛋白,促进泡细胞积累.
- 增加的LDL胆固醇和Lp (a) 加快单细胞/巨细胞的两极分化,使其进入促炎状态.
- 这种C-C化学因子受体2型 (CCR2) 促进单细胞迁移到动脉壁.
- 氧化LDL胆固醇和Lp (a) 可以引发动脉血栓形成,导致急性心血管事件.
结论:
- 单细胞和巨细胞是动脉样硬化开始和进展的核心参与者.
- LDL胆固醇和Lp (a) 显著影响单细胞和巨细胞的行为,加剧动脉样硬化过程.
- 向单细胞/巨细胞通路和脂蛋白相互作用可能为心血管疾病提供治疗策略.
相关概念视频
01:38Inflammation
61.6K
Overview
61.6K
01:30Atherosclerosis I: Introduction
904
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
904
01:26Coronary Artery Disease II: Pathophysiology
366
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
366
01:26Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
01:29Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
01:30Peripheral Artery Disease I: Introduction
310
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
310